Other content tagged: RSV Respiratory Syncytial Virus
Advanced Policy and Advocacy Workshop on RSV 2.0 in Munich
From 12 to 15 September 2024, parent and patient representatives from 18 countries across 2 continents came together to exchange knowledge and learn about effective policy and advocacy activities, using RSV in young children as a case study. It was a pleasure for EFCNI to host this workshop on RSV policy and advocacy in Munich. The four days were packed with practical exercises, engaging group discussions, and workshops aimed at helping participants develop new or enhance existing tools and skills…
Read more
New preliminary study results suggest that new RSV antibody may help reduce infant hospitalisation due to RSV
Interesting first preliminary results from the HARMONIE phase 3b trial on the efficacy of Nirsevimab against RSV (respiratory syncytial virus) infection were presented at the 41st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) in Lisbon in early May. According to these initial results, a single intramuscular dose of this new monoclonal antibody would significantly reduce the frequency of hospitalisations in infants with RSV-associated lower respiratory tract infections (LRTI), suggesting that…
Read more
Beneficial influence of breastfeeding on Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children – a systematic literature review
The Respiratory Syncytial Virus (RSV) poses a significant risk of serious infection in children worldwide, in particular in children in low-income and middle-income countries. However, previous studies indicated that breastfeeding could be a protective factor as it strengthens the immune system and protects against other serious childhood infections. A current systematic review summarises the available evidence on breastfeeding and its effects on acute lower respiratory infections which are associated with RSV. Breastfeeding is officially…
Read more
